Brought to you by 
Cubist buys TerraGen in $29mm stock swap
02 Oct 2000
Executive Summary
Anti-infectives developer Cubist Pharmaceuticals has purchased privately held TerraGen Discovery (biodiversity small-molecule drug discovery) for $29mm in stock. Cubist will issue 608,000 of its common shares in exchange for all of TerraGen's outstanding shares.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
-
Molecular Diversity
- Natural Products
-
Molecular Diversity
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Intra-Biotech Deal
- Payment Includes Stock
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Cubist buys TerraGen in $29mm stock swap
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice